XBiotech Inc buy melinda
Start price
28.04.17
/
50%
€9.80
Target price
04.10.17
€17.14
Performance (%)
-59.43%
End price
04.10.17
€3.98
Summary
This prediction ended on 04.10.17 with a price of €3.98. Massive losses of -59.43% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| XBiotech Inc | 0.000% | 0.000% | 138.924% | -45.917% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by melinda for this prediction
In the thread XBiotech Inc diskutieren
BIOPHARMA
XBiotech, Inc. arbeitet als biopharmazeutisches Unternehmen in der Entdeckung und Entwicklung von echtem humanem monoklonalen Antikörper für die Behandlung einer Vielzahl von diseases.It entwickelt Xilonix ™ zur Behandlung von Darmkrebs Gesellschaft
(Vom Mitglied beendet)